A detailed history of High Tower Advisors, LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 6,244 shares of BIO stock, worth $2.04 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,244
Previous 7,593 17.77%
Holding current value
$2.04 Million
Previous $2.63 Million 35.07%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$268.26 - $339.48 $361,882 - $457,958
-1,349 Reduced 17.77%
6,244 $1.71 Million
Q1 2024

May 06, 2024

BUY
$304.11 - $351.99 $376,792 - $436,115
1,239 Added 19.5%
7,593 $2.63 Million
Q4 2023

Feb 12, 2024

SELL
$269.37 - $365.04 $243,510 - $329,996
-904 Reduced 12.46%
6,354 $2.05 Million
Q3 2023

Nov 08, 2023

BUY
$350.25 - $422.63 $18,913 - $22,822
54 Added 0.75%
7,258 $2.6 Million
Q2 2023

Aug 14, 2023

BUY
$359.49 - $486.4 $301,971 - $408,576
840 Added 13.2%
7,204 $2.73 Million
Q1 2023

May 11, 2023

SELL
$418.69 - $503.0 $59,453 - $71,426
-142 Reduced 2.18%
6,364 $3.05 Million
Q4 2022

Feb 08, 2023

SELL
$351.71 - $456.01 $49,942 - $64,753
-142 Reduced 2.14%
6,506 $2.74 Million
Q3 2022

Nov 09, 2022

SELL
$412.59 - $563.26 $221,148 - $301,907
-536 Reduced 7.46%
6,648 $2.78 Million
Q1 2022

May 12, 2022

BUY
$524.57 - $735.42 $45,113 - $63,246
86 Added 1.21%
7,184 $4.05 Million
Q4 2021

Feb 10, 2022

BUY
$708.84 - $794.68 $2.86 Million - $3.21 Million
4,036 Added 131.81%
7,098 $5.38 Million
Q3 2021

Nov 12, 2021

BUY
$657.71 - $825.77 $336,089 - $421,968
511 Added 20.03%
3,062 $2.27 Million
Q2 2021

Aug 06, 2021

BUY
$576.64 - $649.04 $186,831 - $210,288
324 Added 14.55%
2,551 $1.65 Million
Q1 2021

May 10, 2021

BUY
$547.01 - $662.35 $309,060 - $374,227
565 Added 34.0%
2,227 $1.27 Million
Q4 2020

Feb 10, 2021

SELL
$510.68 - $643.45 $155,246 - $195,608
-304 Reduced 15.46%
1,662 $956,000
Q3 2020

Nov 13, 2020

BUY
$454.43 - $535.6 $123,604 - $145,683
272 Added 16.06%
1,966 $1.03 Million
Q2 2020

Aug 10, 2020

SELL
$334.87 - $493.06 $13,729 - $20,215
-41 Reduced 2.36%
1,694 $765,000
Q1 2020

May 21, 2020

BUY
$320.01 - $409.07 $555,217 - $709,736
1,735 New
1,735 $606,000
Q4 2019

Feb 14, 2020

SELL
$319.73 - $374.2 $614,521 - $719,212
-1,922 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$304.55 - $345.24 $87,101 - $98,738
286 Added 17.48%
1,922 $642,000
Q2 2019

Aug 13, 2019

SELL
$286.93 - $312.59 $45,621 - $49,701
-159 Reduced 8.86%
1,636 $514,000
Q1 2019

May 15, 2019

BUY
$224.3 - $317.41 $76,934 - $108,871
343 Added 23.62%
1,795 $552,000
Q4 2018

Feb 14, 2019

BUY
$220.1 - $309.0 $10,124 - $14,214
46 Added 3.27%
1,452 $335,000
Q3 2018

Nov 09, 2018

BUY
$289.28 - $326.15 $37,317 - $42,073
129 Added 10.1%
1,406 $443,000
Q2 2018

Aug 14, 2018

BUY
$244.1 - $303.88 $38,811 - $48,316
159 Added 14.22%
1,277 $371,000
Q1 2018

May 15, 2018

SELL
$233.97 - $274.11 $112,071 - $131,298
-479 Reduced 29.99%
1,118 $285,000
Q4 2017

Feb 14, 2018

SELL
$216.94 - $271.3 $20,175 - $25,230
-93 Reduced 5.5%
1,597 $381,000
Q3 2017

Nov 14, 2017

SELL
$212.27 - $242.28 $1,273 - $1,453
-6 Reduced 0.35%
1,690 $375,000
Q2 2017

Aug 14, 2017

BUY
N/A
1,696
1,696 $384,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.03B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.